Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Smith

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Nursing Management (Harrow, London, England : 1994)|June 17, 2011
Collaborative project to co-ordinate care for patients with dementiaDorothy Kennerley, Robert Bolas, Jennifer Bourne, et al.
Plos One|August 14, 2010
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicityBarney S Graham, M Juliana McElrath, Michael C Keefer, et al.
The Journal of Infectious Diseases|March 20, 2004
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G proteinPeter F Wright, Jiri Mestecky, M Juliana McElrath, et al.
Human Vaccines & Immunotherapeutics|December 31, 2013
Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in AfricaClaudia Schmidt, Walter Jaoko, Gloria Omosa-Manyonyi, et al.
Plos Neglected Tropical Diseases|May 31, 2014
Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical studyBecky L Rivoire, Nathan A Groathouse, Stephen TerLouw, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineSandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
Plos One|May 24, 2011
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteersSandhya Vasan, Arlene Hurley, Sarah J Schlesinger, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccineSandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, et al.
Human Vaccines & Immunotherapeutics|May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse eventsClaudia Schmidt, Carol Smith, Burc Barin, et al.
Plos One|September 30, 2010
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in AfricaWalter Jaoko, Etienne Karita, Kayitesi Kayitenkore, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Nursing Management (Harrow, London, England : 1994)|June 17, 2011
Collaborative project to co-ordinate care for patients with dementiaDorothy Kennerley, Robert Bolas, Jennifer Bourne, et al.
Plos One|August 14, 2010
Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicityBarney S Graham, M Juliana McElrath, Michael C Keefer, et al.
The Journal of Infectious Diseases|March 20, 2004
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G proteinPeter F Wright, Jiri Mestecky, M Juliana McElrath, et al.
Human Vaccines & Immunotherapeutics|December 31, 2013
Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in AfricaClaudia Schmidt, Walter Jaoko, Gloria Omosa-Manyonyi, et al.
Plos Neglected Tropical Diseases|May 31, 2014
Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical studyBecky L Rivoire, Nathan A Groathouse, Stephen TerLouw, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccineSandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
Plos One|May 24, 2011
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteersSandhya Vasan, Arlene Hurley, Sarah J Schlesinger, et al.
Plos One|January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccineSandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, et al.
Human Vaccines & Immunotherapeutics|May 29, 2012
Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse eventsClaudia Schmidt, Carol Smith, Burc Barin, et al.
Plos One|September 30, 2010
Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in AfricaWalter Jaoko, Etienne Karita, Kayitesi Kayitenkore, et al.
Pageof 8